eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cone rod dystrophy |
| Comorbidity | C0376545|hematologic malignancies |
| Sentences | 4 |
| PubMedID- 21603149 | Phase i/ii clinical trials have started to evaluate safety and toxicity of infusing notch-ligand delta 1 or copper chelator tetraethylenepentamine (tepa; stemex) to induce ex vivo expansion of cord blood progenitors in patients with hematologic malignancies [10, 11]. |
| PubMedID- 20029048 | Combined effect of total nucleated cell dose and hla match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. |
| PubMedID- 21933279 | Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies. |
| PubMedID- 23241738 | Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin. |
Page: 1